Pharma Times

JANUARY 5, 2022

The test is a technological first in determining the metastatic status of a cancer without using prior insight of the primary cancer presented.

162

162

pharmaphorum

JANUARY 5, 2022

A COVID-19 vaccine that could work against multiple variants of the coronavirus – developed by US biotech Gritstone bio – has generated encouraging immune response data in its first clinical trial. The new vaccine differs from the currently approved shots because it delivers antigens for both the spike protein and other proteins found in SARS-CoV-2.

Vaccines 117

Vaccines Immunity Immunization Communication 117

Eye on FDA

JANUARY 5, 2022

FDA has scheduled the first advisory committee meetings of 2022. One meeting of the Oncologic Drugs Advisory Committee is set for February 10 to discuss a new application for the proposed treatment of Non-Small Cell Lung Cancer (NSCLC. And a meeting of the Anesthetic and Analgesic Drug Products Advisory Committee is meeting jointly with the Drug Safety and Risk Management Advisory Committee on February 15 to consider an NDA in the pain category.

Clinical Pharmacology 76

Clinical Pharmacology Vaccines Compounding Diabetes 76

Outsourcing Pharma

JANUARY 3, 2022

An R&D leader from the explains its proactive approach to staying on top of supply chain challenges, including a new dedicated manufacturing line in China.

98

98

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharma Times

JANUARY 4, 2022

Pfizer’s Paxlovid has a success rate of nearly 90% as a prophylaxis treatment against severe COVID-19 when administered shortly after the patient has been infected with the virus.

117

117

pharmaphorum

JANUARY 7, 2022

AstraZeneca has clearly made the rare disease transthyretin amyloidosis (ATTR) a key component of its rare disease pipeline, licensing a second drug candidate in the space of a couple of months. In the latest deal, the pharma group is paying $30 million upfront with another $730 million in milestone’s for global rights to Neurimmune’s NI006, a drug in early-stage clinical for cardiomyopathy, a progressive and fatal complication affecting some patients with ATTR.

Labelling 113

Labelling Immunity Immunization 113

Outsourcing Pharma

JANUARY 4, 2022

An AI expert discusses progress in the field, gaps in understanding, and how predictive modeling and other advanced analytical tools could be put to use.

98

98

Pharma Times

JANUARY 6, 2022

The companies share the goal of furthering knowledge around GPCR biology in immune cells in order to better understand a range of immune system disorders.

Immunity 109

Immunity Immunization 109

pharmaphorum

JANUARY 6, 2022

We spoke with Tanja Dowe, ahead of the annual J.P. Morgan Health Care Conference 2022, about radical innovation in healthcare, including the potential of digital solutions to diagnose disease earlier, using digital therapeutics or preventive digital solutions more efficiently, and making use of technologies that result in accelerated drug discovery and development.

Pharmaceutical Companies 113

Pharmaceutical Companies Pharmaceutical Companies Hospitals 113

NY Times

JANUARY 4, 2022

President Biden announced that his administration would double its order of Pfizer’s scarce Covid-19 antiviral drug, which has been shown to reduce hospitalizations.

Hospitals 59

Hospitals 59

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Outsourcing Pharma

JANUARY 6, 2022

Clover Biopharmaceuticals, a clinical-stage biotech developing novel vaccines and biologic therapeutic candidates, has started construction on a new R&D Center in Zhangjiang Biotech and Pharmaceutical Industrial Base in Shanghai.

Vaccines 92

Vaccines 92

Pharma Times

JANUARY 6, 2022

Testing rules for COVID-19 are set to be eased for those who test positive on a lateral flow test but are asymptomatic.

116

116

pharmaphorum

JANUARY 5, 2022

The FDA thinks an antibody-drug conjugate (ADC) developed by AbbVie could set new standards in treatment for certain patients with lung cancer, awarding the drug breakthrough status. Teliso-V (telisotuzumab vedotin) is pitching to become the first targeted cancer treatment for people with non-small cell lung cancer (NSCLC) whose tumours overexpress c-Met.

Chemotherapy 109

Chemotherapy 109

NY Times

JANUARY 5, 2022

Two of the three parties in Germany’s new governing coalition support legalization, a potentially radical shift in the conservative country.

65

65

Outsourcing Pharma

JANUARY 3, 2022

A representative from IFF Pharma Solutions talks about significant challenges in drug development and improvements the industry can implement to overcome them.

Drug Development 96

Drug Development 96

Pharma Times

JANUARY 4, 2022

In order to help to reduce transmission of the Omicron variant, measures have been instated in hospitals, including a ban on ward visitations.

Hospitals 94

Hospitals 94

pharmaphorum

JANUARY 7, 2022

Kidney cancer is the 14 th most common cancer, with approximately 400,000 new cases worldwide every year. Renal cell carcinoma (RCC) is by far the most prevalent type of cancer originating from the kidney, making up nine out of ten kidney cancer diagnoses. As chief medical officer, head of global medical affairs, patient safety and patient affairs – putting patient interests first is central to my role and values.

104

104

NY Times

JANUARY 4, 2022

President Biden announced that his administration would double its order of Pfizer’s scarce Covid-19 antiviral drug, which has been shown to reduce hospitalizations.

Hospitals 58

Hospitals 58

Outsourcing Pharma

JANUARY 4, 2022

A forward-looking report from company experts includes a breakdown of the top trends to watch for in pharmaceutical development and in healthcare overall.

64

64

Pharma Times

JANUARY 7, 2022

The platform integrates primary human tissue samples into early target and drug discovery research.

113

113

pharmaphorum

JANUARY 7, 2022

If the last couple of days is an indication, 2022 is already shaping up to be the year of big-ticket alliances between big pharma companies and specialists in artificial intelligence-driven discovery. Shortly after Amgen unveiled its $1.9 billion alliance with Generate Biomedicines aimed initially at five drug molecules, Sanofi has announced a big expansion of its longstanding partnership with Exscientia that covers no fewer than 15 programmes.

Immunity 97

Immunity Immunization 97

Drug Patent Watch

JANUARY 7, 2022

Annual Drug Patent Expirations for XYOSTED+%28AUTOINJECTOR%29 Xyosted (autoinjector) is a drug marketed by Antares Pharma Inc and is included in one NDA. It is available from one supplier. There are…. The post New patent for Antares Pharma drug XYOSTED (AUTOINJECTOR) appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Outsourcing Pharma

JANUARY 3, 2022

A leader from the clinical trial technology company says that insights gained during the recent pandemic could be helpful in realizing future improvements.

59

59

Pharma Times

JANUARY 7, 2022

With over 48,000 new cases diagnosed per year, lung cancer is the third most common cancer in the UK.

Chemotherapy 107

Chemotherapy 107

pharmaphorum

JANUARY 6, 2022

The latest pharma company to make a move for an mRNA specialist is Germany’s Merck KGaA, which has offered a $780 million cash buyout to US biotech Exelead. Unlike other recent deals however the takeover isn’t focused on adding a pipeline of mRNA candidates, as Indianapolis-based Exelead is a contract development and manufacturing organisation (CDMO) provide derives to other drugmakers.

Vaccines 95

Vaccines 95

Drug Patent Watch

JANUARY 7, 2022

Annual Drug Patent Expirations for ICLUSIG Iclusig is a drug marketed by Takeda Pharms Usa and is included in one NDA. It is available from one supplier. There are three…. The post New patent for Takeda Pharms drug ICLUSIG appeared first on DrugPatentWatch - Make Better Decisions.

52

52

The Physician Pharmacist

JANUARY 7, 2022

As a pharmacy student interested in a career in medicine, it's imperative that you have an appreciation for the medical school application cycle timeline! It's already hard balancing your pharmacy school obligations, so don't make it harder on yourself by skipping over this crucial timeline! If you know what's on the horizon, you can chart your journey and navigate your application to the promised land!

Medical Schools 52

Medical Schools 52

Pharma Times

JANUARY 5, 2022

Pressure on care and NHS staff mounts with the spread of the latest Omicron variant of COVID-19.

94

94

pharmaphorum

JANUARY 5, 2022

GlaxoSmithKline places shingles vaccine Shingrix is among its top prospects, with peak sales potential of almost $6 billion. Now, Pfizer and BioNTech are joining forces to try to grab a slice of the market. Having already brought their mRNA-based CVID-19 vaccine Comirnaty to market at breakneck speed, Pfizer and BioNTech are hoping to fast-track a vaccine for shingles based on the same technology platform through clinical development, with trials due to start later this year.

Vaccines 93

Vaccines Immunity Immunization 93

Drug Patent Watch

JANUARY 6, 2022

Annual Drug Patent Expirations for EUCRISA Eucrisa is a drug marketed by Anacor Pharms Inc and is included in one NDA. It is available from one supplier. There are four…. The post New patent for Anacor Pharms drug EUCRISA appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Pharma Packaging Solutions

JANUARY 6, 2022

Our theme for 2022 is simple but bold, obvious but too often overlooked. It’s “Jesus 365.” Last Sunday we revisited the story of Jesus’ parents leaving him behind in Jerusalem, losing him for 3 days! It really isn’t a story about safe parenting but a story about God’s calling and our unawareness of God’s absence.

52

52

Pharma Mirror

JANUARY 6, 2022

ADELAIDE, AUS – TrialWire(TM) is pleased to announce new B-cell lymphoma clinical studies are now available on the TrialWire Platform. More than 6 million people have used TrialWire over the past few years to find clinical trials that are right for them at clinics and specialist centers near them. The studies on TrialWire are available in Australia, New Zealand, and the U.S.

52

52

pharmaphorum

JANUARY 5, 2022

The year 2020 ended on a note of hope, with the 8th December vaccination of 91-year-old Margaret Keenan, the world’s first person to receive a COVID-19 vaccine outside clinical trials. Despite an estimated 9.25 billion doses administered globally by 4th January, with 25 different vaccines either approved for use or under emergency use authorisation , 2022 starts on a more sombre note due to the rise of the Omicron variant.

HIV Treatment and Prevention Agents 89

HIV Treatment and Prevention Agents Vaccines 89

Drug Patent Watch

JANUARY 6, 2022

Annual Drug Patent Expirations for CAPLYTA Caplyta is a drug marketed by Intra-cellular and is included in one NDA. There are nine patents protecting this drug. CAPLYTA drug price trends.…. The post New patent for Intra-cellular drug CAPLYTA appeared first on DrugPatentWatch - Make Better Decisions.

Drug Pricing 52

Drug Pricing 52

Pharma Marketing Network

JANUARY 5, 2022

Tune in to this episode of the Pharma Marketing Podcast to hear from our guest, Chris Wasden, Head of Pharma Specialty Solutions & Corporate Strategy at Happify Health and Jennifer Ginest, Digital Marketing Manager of PMN , discuss the current role of Digital Therapeutics in Healthcare and were it is headed.

52

52